Investigational Drugs List

Groups Distribution
Phase Distribution
Filter Conditions

Investigational Drugs List

Drugs ID CID Drugs Identifier Molecular Formula Molecular Weight Groups US Approved Details
Drug191 5744 Hydrocortisone acetate NCT02837432, NCT04148261, NCT04615962, NCT03358082, NCT02671058, NCT02689856, NCT00801957, NCT00610142, NCT00980135, NCT01691209, NCT01228110 C23H32O6 404.50 NULL YES Details
Drug192 8555 Kappadione NULL C11H8Na4O8P2 422.08 NULL NO Details
Drug193 22419 Olsalazine NCT00004288 C14H10N2O6 302.24 approved YES Details
Drug194 162955 Tixocortol NULL C21H30O4S 378.50 NULL YES Details
Drug195 5280933 Gamolenic acid NCT04481724, NCT03914404, NCT00004420 C18H30O2 278.40 NULL NO Details
Drug196 5311066 Desonide NCT03437005, NCT02624544, NCT03386032, NCT03758365, NCT00828412, NCT02732314, NCT02286700, NCT01467362, NCT01542138 C24H32O6 416.50 approved|investigational YES Details
Drug197 71511839 Etelcalcetide NCT03633708, NCT03969329, NCT03960437, NCT03795558, NCT03299244, NCT03283098, NCT01785849, NCT01788046, NCT01896232, NCT02833857, NCT01785875, NCT01932970, NCT01134562, NCT02102204, NCT01134549, NCT01576146, NCT01254565, NCT01414114 C38H73N21O10S2 1048.30 NULL YES Details
Drug198 90311989 Bictegravir NCT04518228, NCT05502341, NCT06333808, NCT06629480, NCT05979311, NCT04805944, NCT03711253, NCT03499483, NCT02275065, NCT02400307 C21H18F3N3O5 449.40 NULL YES Details
Drug199 121488171 Pegunigalsidase alfa NCT05710692, NCT06095713, NCT03566017, NCT06663358, NCT03614234, NCT04552691, NCT02795676, NCT03180840, NCT01981720, NCT03018730, NCT01678898, NCT02921620 C24H44N6O9 560.60 NULL YES Details
Drug200 133065662 Teicoplanin NCT06818565, NCT05914467, NCT04003818, NCT04370145, NCT04341831, NCT02018094, NCT00428844, NCT03020901, NCT01815541, NCT00925093, NCT00024453, NCT00430937, NCT00462878, NCT00454272, NCT00719056, NCT00368498 C88H97Cl2N9O33 1879.70 approved NO Details